Company Monitoring Page for Roche

latest headlines for company on cafepharma

2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Tags:
Biogen, Aduhelm, pharma marketing, Alzheimer's disease, Roche, Eli Lilly
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset
Fierce Biotech
Mon, 12/20/21 - 11:32 pm
Tags:
Roche, Genentech, Lineage Cell Therapeutics, cell therapy, dry age-related macular degeneration
Go or no go? Roche’s fresh start for a new year
EP Vantage
Mon, 12/20/21 - 10:59 am
Tags:
FDA, Roche, Novartis, Pfizer, AstraZeneca, Cibinqo, Lynparza, Tezspire, Vyvgart, faricimab
ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma
Endpoints
Tue, 12/14/21 - 11:12 am
Tags:
ASH2021, Roche, antibody-drug conjugate, Polivy, Genentech, blood cancers
ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio
Endpoints
Sun, 12/12/21 - 11:31 pm
Tags:
ASH2021, Roche, Genentech, bispecific antibodies, blood cancer, mosunetuzumab
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Tags:
Roche, anti-TIGIT, tiragolumab, Tecentriq, lung cancer
Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU
Biopharma Reporter
Tue, 12/7/21 - 11:04 am
Tags:
Roche, Actemra, RoActemra, COVID-19, Europe
Roche Signs Machine-Learning Neuroscience Deal With Recursion
Bloomberg
Tue, 12/7/21 - 10:53 am
Tags:
Roche, Genentech, artificial intelligence, machine learnings, Recursion Pharmaceuticals, cancer, Neuroscience
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Tags:
Roche, Biogen, Alzheimer's disease, Aduhelm, gantenerumab
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Tags:
Regeneron, Roche, COVID-19, antibodies
Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: report
Fierce Pharma
Thu, 11/18/21 - 10:50 am
Tags:
Novartis, Roche, M&A, Alnylam
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
Fierce Biotech
Wed, 11/17/21 - 10:28 am
Tags:
Roche, Merck, Pfizer, Atea Pharmaceuticals, COVID-19
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
Thu, 11/11/21 - 10:59 am
Tags:
AC Immune, Roche, anti-tau antibodies, Alzheimer's disease
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis, M&A, Roche, Sandoz, Aurinia Pharmaceuticals, Alnylam, Exelixis, Incyte, Eisai, Genmab
Novartis to sell its Roche stake for $20.7 billion
Axios
Thu, 11/4/21 - 10:54 am
Tags:
Novartis, Roche
Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer
Xtalks
Wed, 10/27/21 - 10:58 am
Tags:
Genentech, Roche, ocular implant delivery, macular degeneration, FDA, wet age-related macular degeneration
FDA clears Roche’s Susvimo implant for eye disease wet AMD
Pharmaforum
Sun, 10/24/21 - 10:38 pm
Tags:
Roche, Genentech, FDA, Susvimo, wet age-related macular degeneration
Delta variant keeps Roche diagnostics sales sky high
Pharmaforum
Wed, 10/20/21 - 10:11 am
Tags:
Roche, diagnostics, COVID-19, earnings
Atea’s antiviral pill fails to clear Covid-19, forcing a re-think
Stat
Tue, 10/19/21 - 10:48 am
Tags:
Atea Pharmaceuticals, COVID-19, antivirals, clinical trials, Roche, AT-527
Roche scores adjuvant lung cancer approval for Tecentriq
Pharmaforum
Mon, 10/18/21 - 11:00 am
Tags:
Roche, Tecentriq, FDA, non-small cell lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.